- Home
- / Stem Cell Research Institute
Stem Cell Research Institute
Stock Price
¥1.8 K
2024-10-29
Market Capitalization
¥18.6 B
2024-10-29
Revenue
¥2.8 B
FY, 2026
Stem Cell Research Institute Summary
Company Summary
- Overview
- Stem Cell Research Institute (株式会社ステムセル研究所) is a provider of stem cell banking business. It isolates and cryopreserves cord blood cells and umbilical cord tissues for use in regenerative medicine, etc.
- Type
- Public
- Status
- Active
- Founded
- 1999
- Cybersecurity rating
- Sectors
Table of Contents
Stem Cell Research Institute Financials
Summary Financials
- Revenue (FY, 2026)
- ¥2.8B
- Gross profit (FY, 2026)
- ¥1.9B
- Net income (FY, 2026)
- ¥131.0M
- Cash (FY, 2026)
- ¥2.8B
- EBIT (FY, 2026)
- ¥204.6M
- Enterprise value
- $16.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026